Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer. (Q39683901)
Jump to navigation
Jump to search
scientific article published on 6 July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer. |
scientific article published on 6 July 2010 |
Statements
Inhibition of androgen receptor and Cdc25A phosphatase as a combination targeted therapy in molecular apocrine breast cancer (English)